article thumbnail

Bristol Myers Squibb Awards “Golden Tickets” to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabsf

The Pharma Data

A private,non-profit institution, LabCentral was innovated in 2013 as a helipad for high implicit life- lores and biotech startups. Each point has a complete molecular biology core installation that allows companies to do trials on day one. Since opening in 2013, MBC BioLabs has helped launch and grow 230 companies.

article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Cell Mol Immunol 10(1):21-9 (2013). and MBA students with real-world consulting experiences. Kalyan S, Kabelitz D.

Therapies 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket

The Pharma Data

Each site has a complete molecular biology core facility that allows companies to do experiments on day one, not year one. Our labs have truly enabled awesome: since our opening in 2013 we have helped launch and grow 194 companies. For more information, visit www.MBCBioLabs.com.

article thumbnail

CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) Published in Science Translational Medicine

The Pharma Data

Professor in the School of Medicine in the Department of Molecular and Cellular Physiology, and in Neurology, Psychiatry and Behavioral Sciences at Stanford University, a 2013 Nobel Prize winner in Physiology/ Medicine, a Howard Hughes Medical Institute investigator, and Chair of CytoDel’s Scientific Advisory Board. “We Südhof, M.D.,

Science 52
article thumbnail

Using AI to predict metastatic behaviour of NSCLC

Drug Target Review

Dr Cote began his career at the University of Southern California Keck School of Medicine, rising to Professor in departments of Pathology and Urology and Director in the Genitourinary Cancer Program, Laboratory of Immunology and Molecular Pathology and USC Biomedical Nanoscience Initiative. In 2009, he became the Joseph R. Coulter Jr.

article thumbnail

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

Broad Institute

Christian Happi and Pardis Sabeti on the campus of Redeemer's University in 2013. Christian Happi and Pardis Sabeti on the campus of Redeemer's University in 2013. In 2013, Happi and Sabeti applied to the World Bank for support to establish a genomic center of excellence in Nigeria. Scientists train at ACEGID in October 2013.

Virus 132
article thumbnail

A clinical genomicist harnesses team-based science to help rare-disease patients

Broad Institute

From her first biology course in high school, Rehm loved the logic of genetics: the clear trajectory from a simple code of DNA to RNA to proteins and how disrupting that process could lead to disease. NCBI then launched the ClinVar database in 2013 to house that information in a public archive.

Disease 121